Phase I Nicotinic Agonist Treatment Trial for Autism
NCT02111551
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
difficult to find participants and no funding
Conditions
Autism
Interventions
DRUG:
DMXB-A 150 mg
OTHER:
placebo
DRUG:
DMXB-A 75 mg
Sponsor
University of Colorado, Denver